DOCSLIB.ORG

Hydroxyurea Use in Sickle Cell Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hydroxyurea Use in Sickle Cell Disease Hemoglobinopathies Matthew M. Heeney, MD Associate Chief – Hematology Director – Sickle Cell Program Boston Children’s Hospital THE FAIRMONT COPLEY PLAZA HOTEL BOSTON, MA. SEPTEMBER 23-28, 2018 Faculty Disclosure Matthew M. Heeney, MD Personal financial interests in commercial entities that are relevant to my presentation(s) or other faculty roles: • Astra Zeneca Consultant, Clinical Trial funding • Pfizer Clinical Trial funding • Micelle Biopharma Consultant, Clinical Trial funding • Novartis Consultant Objective • Review the basic genetics of globins • Review – Qualitative disorders of hemoglobin • Sickle Cell disease • Other Hemoglobinopathies – Quantitative disorders of hemoglobin • Thalassemias 3 Hemoglobin • Four globular proteins (globins) – 2 α-like globins – 2 β-like globins • Four heme groups – One per globin chain – Reversibly bind O2 (CO2, NO) • Hb synthesis must be balanced and coordinated • All components are labile and toxic – globins, heme, iron 4 Globin Genes Nathan and Oski's Hematology of Infancy and Childhood, 7th Ed. 5 Globin Protein Synthesis Nathan and Oski's Hematology of Infancy and Childhood, 7th Ed. 6 Hemoglobin tetramers • Hemoglobins are distinguished by globin composition: % nl adult HbA α2β2 97-98% HbA2 α2δ2 2-3% HbF α2γ2 ≤2% S HbS: α2β 2 0% C HbC: α2β 2 0% HbH: β4 0% Hb Barts: γ4 0% 7 Global distribution of hemoglobin disorders • Distribution of thalassemia & sickle cell disease mirror worldwide distribution of malaria prior to 20th century. • Hypothesis (Haldane and others): heterozygous forms confer fitness - Thalassemia trait, sickle trait, G6PD etc.. protective against death from cerebral falciparum malaria. “Benefit” of trait WHO - Control of Hereditary diseases. 1996 outweighs homozygous risk. 8 Disorders of Hemoglobin Qualitative disorders – Structural variants or hemoglobinopathies – Production of abnormal globin chains Quantitative disorders – Thalassemias – Decreased (imbalanced) production of normal globin chains 9 Qualitative Disorders of Hemoglobin SICKLE CELL DISEASE 10 1910 First description of sickle cell anemia in a West Indian dental student with “peculiar elongated and sickle-shaped” red blood cells. James B. Herrick Presbyterian Hospital Chicago, Illinois Herrick JB. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Archives of Internal Medicine 1910. 6(5): 517-211 11 1949 Established sickle cell anemia as a genetic disease in which affected individuals have a different forms of Linus Pauling hemoglobin in their California Institute of Technology blood Pasadena, CA Pauling L et al. Sickle Cell, A Molecular Disease. Science. 110 (2865): 543–548. 12 1956 Vernon Ingram and J.A. Hunt working at MIT, discovers the single amino acid change that causes hemoglobin to sickle Sickle cell anemia became the 1st genetic Vernon Ingram disorder whose molecular basis was Cavendish Laboratory, University of Cambridge known. Ingram VM. A Specific Chemical Difference between Globins of Normal and Sickle-cell Anemia Hemoglobins" Nature. 178 (4537): 792–794 13 Epidemiology Most common single gene disorder in African Americans 1/375 homozygous affected 1/12 are heterozygous carriers (~8%) Also affects other ethnicities: India Middle East Hispanic U.S. Prevalence: 80,000 – 120,000 U.S. Incidence: ~2000 live births annually 14 Sickle cell and malaria Distribution of endemic malaria Distribution of sickle cell allele Muntuwandi at en.wikipedia 15 Molecular Pathophysiology - Polymerization The sickle mutation is a single amino acid substitution at position 6 of β globin. Results in a hydrophobic region that is exposed in the deoxygenated state. Adapted from Rotter MA et al. Biophys J. 2005 Oct;89(4):2677-84.. 16 Bunn HF. NEJM. 1997 Sep 11;337(11):762-9 17 Delay time • Delay time: period during which Hb is deoxygenated, but not yet polymerized • If passage through the capillaries exceeds the delay time, Hb will aggregate and initiate sickling. 18 Cellular Pathophysiology Polymerization leads to: • Distortion of cell shape • Damage to RBC membrane • Abnormal permeability • Irreversible sickling Premature hemolysis = Anemia Impairment of RBC flow = Infarction 19 Hemolysis and Nitric Oxide depletion • ↓ NO • Endothelial dysfunction 20 Dichotomization of Pathophysiology? Adapted from Kato GJ et al. Blood Rev. 2007 Jan; 21(1): 37–47. 21 Manwani D and Frenette PS Blood. 2013:122(24):3892-3898 22 Vaso-occlusion Intra-cellular dehydration Endothelial Activation Hemolysis Inflammation Reperfusion Injury Nitric Oxide consumption 23 23 Sickle cell genotypes Genotype Characteristics Hb SS Anemia : Hb 7 - 9 g/dL “Sickle cell anemia” Smear: Irreversibly sickled cells Electrophoresis: Hb S, Hb F Hb SC Anemia: Hb 9 - 11 g/dL Smear: Sickle and target cells Electrophoresis: Hb S and Hb C Hb S/β0 thalassemia Anemia: Hb 7 - 9 g/dL Smear: Microcytosis with sickle and target cells Electrophoresis: Hb S, Hb F Hb S/β+ thalassemia Anemia: Hg > 10 g/dL Smear: Microcytosis with sickle and target cells Electrophoresis: Hb S, Hb F, and small %Hb A 24 Primary pathological processes in SCD Vaso-occlusion Chronic Hemolysis • Pain episodes / “crises” • Cholelithiasis • Acute chest syndrome • Folate deficiency • Avascular necrosis • Cardiomegaly • Splenic sequestration • High-output heart failure (mostly in children) • Liver disease from iron overload (with repeated • Renal insufficiency transfusions) • Proliferative retinopathy • Non-hemorrhagic stroke (HbSC > HbSS) • Pulmonary hypertension • Excess fetal loss • Leg ulcers • Priapism 25 Infection in SCD • Functional asplenia Sepsis from encapsulated organisms AA SS • Osteomyelitis Salmonella and Staphylococcus aureus • Aplastic crisis (Parvovirus B19) • Hepatitis B and C (from transfusion) 26 Acute chest syndrome (ACS) • Clinical syndrome of – Fever, – Respiratory symptoms (e.g. hypoxia, tachypnea) – New pulmonary infiltrate 27 Acute chest syndrome (ACS) • 2nd most common cause of hospitalization. • Most common cause of death in sickle cell anemia. • Increased mortality with poorly controlled asthma • Prevent atelectasis – Control chest pain, incentive spirometry • O2 and trial of bronchodilators • Often associated with atypical organisms (e.g. chlamydia, mycoplasma). – Empiric broad-spectrum antibiotics + macrolide • Simple or exchange transfusion may be life-saving 28 Stroke Ohene-Frempong et al Blood. 1998; 91(1):288-94. 29 Stroke Ohene-Frempong et al Blood. 1998; 91(1):288-94. 30 Stroke Risk Assessment Transcranial Doppler ultrasound (TCD) is a reproducible, non-invasive technique to predict 1° stroke risk in children < 170 cm/sec “Normal” 170 – 199 cm/sec “Conditional” > 200 cm/sec “Abnormal” 31 Stroke Risk Assessment R.R. of stroke with Abnormal TCD = 44 (95% CI = 5.5 - 346) Adams et al. Ann Neurol 1997; 42:699 -704 32 Transfusion therapy for stroke prevention Effect of chronic Effect of chronic transfusion on 1° transfusion on 2° stroke rate in an stroke probability. asymptomatic patients with elevated TCD. (“STOP” Trial) Effect on stroke rate Incident rate of stroke of discontinuing in SS children living in chronic transfusion in California (CA), asymptomatic before and after patients with publication of the elevated TCD from STOP Trial STOP Trial. (“STOP2” Trial) Adapted from: Platt OS. Hematology 2006.. 2006:54-57 (ASH Education Book 2006) 33 Acute Transfusion therapy • Goal – maximize O2-carrying capacity • Post –transfusion Hb should not exceed 10-11 g/dL Platt OS. Hematology 2006.. 2006:54-57 • Transfuse phenotypically matched blood for minor antigens C, E and Kell • Allo-sensitization should be reassessed 1-3 months after episodic transfusions 34 Chronic transfusion therapy Benefits: • Protection from CVA, ACS Risks • Iatrogenic Fe overload • Allo-sensitization • Unknown Infectious Risk 35 Perioperative management of SCD • Preoperative period – Admit to hospital 12 to 24 hours before surgery for hydration. – Treat obstructive lung disease with bronchodilators. – Simple transfusion to a Hb 10-11g/dL except for minor operations. • Intraoperative period – Maintain oxygen therapy with pulse oximetry. – Maintain hydration. – Prevent hypothermia. – Monitor blood loss and replace blood when necessary. • Postoperative period – Pulse oximetry, IV fluids, incentive spirometry. – Monitor for development of acute chest syndrome. 36 Role of fetal hemoglobin in sickle cell disease • Sickle cell phenotype only occurs after ~ 6months of age • Hemoglobin F levels are inversely correlated with disease severity / mortality • Biochemical evidence that gamma globin disrupts sickle globin polymerization 37 Hydroxyurea • The only FDA approved agent for sickle cell disease. • Old drug – New indication. • first synthesized in 1869 • anti-neoplastic since the 1960’s • mechanism of action unclear. • ribonucleotide reductase inhibitor. • Mechanism • ↑ Hemoglobin F • ↓ HbS polymerization and hemolysis • ↑ Hemoglobin • ↓ White Blood Cells (“Side-Effect”?) 38 Hydroxyurea – Clinical Trials MultiCenter Study of Hydroxyurea (MSH) (1992-1995) • Adults • ↑ Hemoglobin F; ↓ Hemolysis & Anemia; ↓ white blood cells • ↓ pain crises by 40%; ↓ acute chest syndrome by 50%; ↓ transfusions by 50% Charache S et al. N Engl J Med 1995;332:1317-1322. MSH Follow-Up (1996-2001) • 40% reduction in mortality after 9 years of follow-up Steinberg MH et al JAMA. 2003;289(13):1645-1651 MSH Follow-Up (1996-2010) • after 17.5 years of follow-up Steinberg MH et al. Am J Hematol 2010;85: 403–408. 39 MSH Follow-up – Cumulative Mortality Steinberg MH et al. Am J Hematol 2010;85: 403–408.
Load more

Recommended publications
  • Vernon M. Ingram the WILLIAM ALLAN MEMORIAL AWARD Presented at the Annual Meeting of the American Society of Human Genetics Toronto December 1, 1967
    Vernon M. Ingram THE WILLIAM ALLAN MEMORIAL AWARD Presented at the annual meeting of the American Society of Human Genetics Toronto December 1, 1967 CITATION The contributions for which we honor Vernon Ingram represent a landmark in the history of molecular biology. Using an ingenious technique, he showed in 1956 that the difference between normal and sickle hemoglobin was caused by a single amino acid substitution. This work, followed by his demonstration of a similar mechanism for hemoglobin C and hemo- globin E, established clearly the nature of mutations in structural proteins and laid the groundwork for our concepts of gene action on the molecular level. 287 288 THE WILLIAM ALLAN MEMORIAL AWARD Vernon Ingram's investigations played a key role in the full integration of human genetics into the mainstream of modern genetic research. For the first time in the history of genetics, a phenomenon of fundamental significance for all forms of life was first demonstrated in man. Human genetics had come of age and became respectable to our more basically inclined colleagues. Vernon Ingram, as a scientist, represents a model for our students. Some investigators are analytical, while others are synthesizers and paint a broad sweep. Some are lone workers, others perform better in a team. Most biologists work in one field-within the framework of Ingram's interests, either as biochemists, as hematologists, as geneticists, or as evolutionists. Vernon Ingram has performed with versatility and distinction in all of these roles. As an analytical chemist, he developed the "fingerprinting" method of peptide separation, which he used to test theories of mutations.
    [Show full text]
  • Sequencing As a Way of Work
    Edinburgh Research Explorer A new insight into Sanger’s development of sequencing Citation for published version: Garcia-Sancho, M 2010, 'A new insight into Sanger’s development of sequencing: From proteins to DNA, 1943-77', Journal of the History of Biology, vol. 43, no. 2, pp. 265-323. https://doi.org/10.1007/s10739-009- 9184-1 Digital Object Identifier (DOI): 10.1007/s10739-009-9184-1 Link: Link to publication record in Edinburgh Research Explorer Document Version: Peer reviewed version Published In: Journal of the History of Biology Publisher Rights Statement: © Garcia-Sancho, M. (2010). A new insight into Sanger’s development of sequencing: From proteins to DNA, 1943-77. Journal of the History of Biology, 43(2), 265-323. 10.1007/s10739-009-9184-1 General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 28. Sep. 2021 THIS IS AN ADVANCED DRAFT OF A PUBLISHED PAPER. REFERENCES AND QUOTATIONS SHOULD ALWAYS BE MADE TO THE PUBLISHED VERION, WHICH CAN BE FOUND AT: García-Sancho M.
    [Show full text]
  • Perutz Letters
    04_PerutzLet_1950_223-272.qxd:Layout 1 1/12/09 12:26 PM Page 261 Copyright 2009 Cold Spring Harbor Laboratory Press. Not for distribution. Do not copy without written permission from Cold Spring Harbor Laboratory Press. Selected Letters: 1950s 261 To Harold Himsworth, August 24, 1956 I am writing to tell you of exciting developments in the work of our unit. The first news is the discovery by Dr. Vernon Ingram of a definite chemi- cal difference between the globins of sickle cell anaemia and normal haemo- globin. Ingram has devised a new and rapid method of characterising proteins in considerable detail. This consists in first digesting the protein with trypsin and then spreading out the peptides of the digest on a two-dimensional chro- matogram, using electrophoresis in one direction and chromatography in the other. By applying this method to the two haemoglobins Ingram finds that all the 30 odd peptides in the digest are alike except for a single one. This peptide is uncharged in normal haemoglobin and carries a positive charge in haemo- globin S. The size of the peptide is probably of the order of 10 amino-acid residues. Ingram is now going to set about to determine the composition and sequence of the residues in the two peptides. This discovery is particularly interesting, Vernon Ingram in the because the change in structure from normal to early 1950s sickle cell haemoglobin is thought to be due to the action of one single gene, and the action of genes is thought to consist in determining the sequence of residues in a polypeptide chain.
    [Show full text]
  • Max Perutz (1914–2002)
    PERSONAL NEWS NEWS Max Perutz (1914–2002) Max Perutz died on 6 February 2002. He Nobel Prize for Chemistry in 1962 with structure is more relevant now than ever won the Nobel Prize for Chemistry in his colleague and his first student John as we turn attention to the smallest 1962 after determining the molecular Kendrew for their work on the structure building blocks of life to make sense of structure of haemoglobin, the red protein of haemoglobin (Perutz) and myoglobin the human genome and mechanisms of in blood that carries oxygen from the (Kendrew). He was one of the greatest disease.’ lungs to the body tissues. Perutz attemp- ambassadors of science, scientific method Perutz described his work thus: ted to understand the riddle of life in the and philosophy. Apart from being a great ‘Between September 1936 and May 1937 structure of proteins and peptides. He scientist, he was a very kindly and Zwicky took 300 or more photographs in founded one of Britain’s most successful tolerant person who loved young people which he scanned between 5000 and research institutes, the Medical Research and was passionately committed towards 10,000 nebular images for new stars. Council Laboratory of Molecular Bio- societal problems, social justice and This led him to the discovery of one logy (LMB) in Cambridge. intellectual honesty. His passion was to supernova, revealing the final dramatic Max Perutz was born in Vienna in communicate science to the public and moment in the death of a star. Zwicky 1914. He came from a family of textile he continuously lectured to scientists could say, like Ferdinand in The Tempest manufacturers and went to the Theresium both young and old, in schools, colleges, when he had to hew wood: School, named after Empress Maria universities and research institutes.
    [Show full text]
  • Genetic Testing
    GENETIC TESTING The transcript of a Witness Seminar held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 13 July 2001 Edited by D A Christie and E M Tansey Volume 17 2003 CONTENTS Illustrations v Introduction Professor Peter Harper vii Acknowledgements ix Witness Seminars: Meetings and publications xi E M Tansey and D A Christie Transcript Edited by D A Christie and E M Tansey 1 References 73 Biographical notes 91 Glossary 105 Index 115 ILLUSTRATIONS Figure 1 Triploid cells in a human embryo, 1961. 20 Figure 2 The use of FISH with DNA probes from the X and Y chromosomes to sex human embryos. 62 v vi INTRODUCTION Genetic testing is now such a widespread and important part of medicine that it is hard to realize that it has almost all emerged during the past 30 years, with most of the key workers responsible for the discoveries and development of the field still living and active. This alone makes it a suitable subject for a Witness Seminar but there are others that increase its value, notably the fact that a high proportion of the critical advances took place in the UK; not just the basic scientific research, but also the initial applications in clinical practice, particularly those involving inherited disorders. To see these topics discussed by the people who were actually involved in their creation makes fascinating reading; for myself it is tinged with regret at having been unable to attend and contribute to the seminar, but with some compensation from being able to look at the contributions more objectively than can a participant.
    [Show full text]
  • Biographical Description for the Historymakers® Video Oral History with J
    Biographical Description for The HistoryMakers® Video Oral History with J. K. Haynes PERSON Haynes, John Kermit, 1943- Alternative Names: J. K. Haynes; Life Dates: October 30, 1943- Place of Birth: Monroe, Louisiana, USA Residence: College Park, GA Work: Atlanta, GA Occupations: Academic Administrator; Biologist; Biographical Note Biologist and academic administrator John K. “J.K.” Haynes was born on October 30, 1943 in Monroe, Louisiana to John and Grace Haynes. His mother was a teacher and his father was the principal of Lincoln High School in Ruston, Louisiana. Haynes began first grade when he was four years old. When he was six, his family moved to Baton Rouge, Louisiana and Haynes began attending Southern University Laboratory School. He attended Morehouse College Laboratory School. He attended Morehouse College when he was seventeen and he received his B.S. degree in biology in 1964. Haynes aspired to attend medical school. However, a professor advised him to apply to graduate school and he went on to attend Brown University, where he obtained his Ph.D. degree in biology in 1970. Haynes completed his first year of postdoctoral research at Brown University, where he worked on restriction enzymes. During this time, he became interested in sickle cell anemia, which led to a second postdoctoral appointment in biochemistry at Massachusetts Institute of Technology (MIT), where he worked with Vernon Ingram, the scientist who discovered the amino acid difference between normal and sickle cell hemoglobin. In 1973, Haynes joined the faculty at the Meharry Medical School as a junior faculty member in the department of genetics and molecular medicine and the department of anatomy.
    [Show full text]
  • The Patient-Physician Relationship in Sickle-Cell Disease at Yale-New Haven Hospital
    Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 1991 The ap tient-physician relationship in sickle-cell disease at Yale-New Haven Hospital Douglas Theodore Fleming Yale University Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl Recommended Citation Fleming, Douglas Theodore, "The ap tient-physician relationship in sickle-cell disease at Yale-New Haven Hospital" (1991). Yale Medicine Thesis Digital Library. 2592. http://elischolar.library.yale.edu/ymtdl/2592 This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. g|g # ;.I§§| ill i :|| I ;|||||||||pai if ilii'lY iii Ifsj3 III Douglas T:;oioooro ReiTrit Yale University YALE MEDICAL LIBRARY Digitized by the Internet Archive in 2017 with funding from The National Endowment for the Humanities and the Arcadia Fund https://archive.org/details/patientphysicianOOflem The Patient-Physician Relationship in Sickle-Cell Disease at Yale-New Haven Hospital A Thesis Submitted to the Yale University School of Medicine in Partial Fulfillment of the Requirements for the Degree of Doctor of Medicine By Douglas Theodore Fleming (1991) [M, f d ■ L t Id . T f * S ^ < 4 Dedication This thesis is dedicated with great affection to: o My wife, Robin Buckingham, the light of my life, and to o My parents, Betty and Robert Fleming, whose support for me through my life and education has been unfailing.
    [Show full text]
  • Genetic Testing (V19) 3/11/03 8:46 Pm Page I
    Genetic Testing (v19) 3/11/03 8:46 pm Page i GENETIC TESTING The transcript of a Witness Seminar held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 13 July 2001 Edited by D A Christie and E M Tansey Volume 17 2003 ©The Trustee of the Wellcome Trust, London, 2003 First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2003 The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 085484 094 6 All volumes are freely available online at: www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/ Please cite as: Christie D A, Tansey E M. (eds) (2003) Genetic Testing. Wellcome Witnesses to Twentieth Century Medicine, vol. 17. London: Wellcome Trust Centre for the History of Medicine at UCL. Key Front cover photographs, top to bottom: Professor Marcus Pembrey Dr Patricia Tippett Professor Doris Zallen Professor Sir David Weatherall, Professor Charles Rodeck Inside front cover photographs, top to bottom: Professor John Woodrow Professor Rodney Harris Professor John Edwards (1928–2007) Professor Sue Povey Back cover photographs, top to bottom: Professor Ursula Mittwoch Professor Malcolm Ferguson-Smith Professor Matteo Adinolfi Professor Paul Polani (1914–2006) Inside back cover photographs, top to bottom: Professor Matteo Adinolfi, Professor Paul Polani (1914–2006) Professor Paul Polani (1914–2006), Professor Rodney Harris Professor Bernadette Modell Mrs Cathy Holding, Professor Alan Handyside Genetic Testing (v19) 3/11/03 8:46 pm Page iii CONTENTS Illustrations v Introduction Professor Peter Harper vii Acknowledgements ix Witness Seminars: Meetings and publications xi E M Tansey and D A Christie Transcript Edited by D A Christie and E M Tansey 1 References 73 Biographical notes 91 Glossary 105 Index 115 Genetic Testing (v19) 3/11/03 8:46 pm Page iv Genetic Testing (v19) 3/11/03 8:46 pm Page v ILLUSTRATIONS Figure 1 Triploid cells in a human embryo, 1961.
    [Show full text]
  • Finding Aid to the Historymakers ® Video Oral History with J. K. Haynes
    Finding Aid to The HistoryMakers ® Video Oral History with J. K. Haynes Overview of the Collection Repository: The HistoryMakers®1900 S. Michigan Avenue Chicago, Illinois 60616 [email protected] www.thehistorymakers.com Creator: Haynes, John Kermit, 1943- Title: The HistoryMakers® Video Oral History Interview with J. K. Haynes, Dates: April 14, 2011 Bulk Dates: 2011 Physical 6 uncompressed MOV digital video files (2:33:59). Description: Abstract: Academic administrator and biologist J. K. Haynes (1943 - ) developed methods for detecting and preventing sickle cell anemia. He joined the faculty of Morehouse College in 1979 and later became Dean of the Division of Science and Mathematics. Haynes was interviewed by The HistoryMakers® on April 14, 2011, in Atlanta, Georgia. This collection is comprised of the original video footage of the interview. Identification: A2011_013 Language: The interview and records are in English. Biographical Note by The HistoryMakers® Biologist and academic administrator John K. “J.K.” Haynes was born on October 30, 1943 in Monroe, Louisiana to John and Grace Haynes. His mother was a teacher and his father was the principal of Lincoln High School in Ruston, Louisiana. Haynes began first grade when he was four years old. When he was six, his family moved to Baton Rouge, Louisiana and Haynes began attending Southern University Laboratory School. He attended Morehouse College when he was seventeen and he received his B.S. degree in biology in 1964. Haynes aspired to attend medical school. However, a professor advised him to apply to graduate to attend medical school. However, a professor advised him to apply to graduate school and he went on to attend Brown University, where he obtained his Ph.D.
    [Show full text]
  • Data, Theory, and Scientific Belief in Early Molecular Biology
    Data, Theory, and Scientific Belief in Early Molecular Biology Pauling’s and Crick’s Conflicting Notions About the Genetic Determination of Protein Synthesis and the Solution to the ‘Secret of Life’ Ute Deichmann Abstract : Motivated by the contradictory arguments about the relationship between data and theory in science, such as the holistic, data relativizing Du- hem/Quine thesis of the underdetermination of theory by data, and a new empiricism, according to which the availability of large amounts of data is a sufficient basis for objective science, I analyze, both historically and conceptu- ally, the generation of two highly important conflicting theories in early mo- lecular biology: Linus Pauling’s structural and Francis Crick’s informational theory of biological specificity and protein synthesis. My goals are: (1) To ex- plore the relationship between experimental data, knowledge, and theory in Pauling’s and Crick’s theories. (2) To show that both Pauling and Crick based their views on only a few, and almost the same, experimental data, evaluating them, however, from the different perspectives of structural chemistry and in- formational biology. (3) To argue that despite the apparent equivalence of da- ta, the theories themselves were not equivalent, scientific theory choice was possible on the basis of knowledge beyond the direct experimental data, and that in general data does not speak for itself. Keywords : underdetermination, subjectivity, protein synthesis, template theories, sequence hypothesis . 1. Introduction Starting with the Human Genome Project and the availability of unprece- dented amounts of sequencing data and powerful computational techniques, a new type of biology that is ‘data-driven’, not ‘hypothesis-driven’, has been proclaimed (Aebersold et al .
    [Show full text]
  • Questions on the Crum VII, 1998 Packet by Princeton A- and Penn CID
    Mix 1: Questions on the Crum VII, 1998 Packet by Princeton A- and Penn CID Note: Backup Packet 1) This disease was first observed in 1904 in Chicago by physician James Herrick and Ernest Irons, a medical intern. More than fifty years later, in 1957, Vernon Ingram demonstrated that it was caused by the substitution of glutamic acid by valine in the sixth amino acid spot of the beta chain. Selected for evolutionarily because heterozygosity conveys malaria resistance, FfP, name this disease that affects, in one out of every four-hundred Mrican-Americans, the hemoglobin protein. Ans: SICKLE-CELL ANEMIA 2) He studied physics at the University of Allahabad before leaving for the Himalayas to study under Guru Dev. Later, his own teachings spread throughout the world, forming the basis for the Natural Law Party. FfP, name this popularizer of transcendental meditation, also serving as mystical guru to the Beatles. Ans: _Maharishi_ Mahesh Yogi 3) Although he studied law at Leipzig and Heidelberg, his real love was music, despite the fact that physical difficulties in his right hand prevented him from playing the piano. He also assumed the role of the critic in the founding of the "Zeitchrift fur Musik", which became the most important music journal in Europe. FfP, name this composer whose works were expressed through the talents of Clara Wieck. Ans: Robert SCHUMANN 4) Unlike MRl, this non invasive imaging technique allows functional mapping of the brain's activity. Using dozens or hundreds of Superconducting Quantum Interference Devices, or SQUIDs, it is the active measurement of the femtotesla magnetic fields outside the skull caused by the brain's currents.
    [Show full text]
  • Ingram Sickle Cell Hemoglobin Lesson
    History of the Analysis of Hemoglobin and Sickle Cell Anemia During this activity, you will be exploring the scientific foundations of protein research and both the genetic and biochemical basis for the disease Sickle Cell Anemia. Analyze the timeline below. Read and discuss the papers and data provided by your instructor. Read the prompts and follow the directions provided on this sheet in order to analyze the data and answer the questions that follow. An historical perspective: Gregor Mendel first published his research on inheritance in 1865. Fast forward 88 years to 1953 when Watson & Crick published their famous paper reporting the structure of DNA. In the years surrounding Watson & Crick’s research, much was going on in the world of genetics and protein discovery. Vernon Ingram, among others, did a great deal of research on hemoglobin and the gene mutation that causes Sickle Cell Anemia. Keep in mind, however, that the central dogma of biology (DNA → RNA → Protein) and the exact relationship between DNA and protein, while discussed and hypothesized, had not yet been solidified at the time of this research. 1953: James Watson and 1865: Gregor Mendel publishes 1910: James Herrick is 2003: J. Craig Venter and Francis Crick publish paper research on inheritance. first to document sickle Francis Collins complete on structure of DNA. cell anemia. Human Genome Project. 1954: Tony Allison described the 1961: Corrado Baglioni improves tryptic digest heterozygote advantage of sickle cell trait. of hemoglobin; confirms difference in 1949: Jim Neel showed sickle cell peptides. anemia is caused by homozygosity for a gene; Linus Pauling called sickle cell anemia the first “molecular disease.” 1956-57: Vernon Ingram 1951: Fred Sanger & Hans compares the tryptic digests Tuppy demonstrated for of normal and sickle cell the first time that a hemoglobin.
    [Show full text]